Glenmark Pharma Q2 Results : Co posts Rs 355 crore net profit on robust sales (...)
Glenmark Pharma reported Rs 340 crore net profit in Q2FY25 led by robust sales growth in India and Europe. The drugmaker reported a net loss of Rs 180 crore in the corresponding quarter of the previous year.
Site référencé: The Economic Times
The Economic Times
Analysts warn of further weakness if Nifty fails to hold 24,500 level
4/08/2025
India's banks face decline in CASA ratios impacting net interest margins
4/08/2025
FPIs inject Rs 14,247 crore into Indian primary market in July amid IPO surge
4/08/2025
Nifty logs longest losing streak in 2 years : SBI Securities' Sudeep Shah on what traders should do now
3/08/2025
Bangladesh tribunal commences trial of deposed PM Hasina over crimes against humanity
3/08/2025
These 10 stocks delivered consistent dividend yields over the last 3 years
3/08/2025
